Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Pres Cell Therapy, VP Corp Dev
-
Issuer Symbol
-
ATNXQ
There are no Buy or Sell transactions made by Daniel Lang since 12 Mar 2025
Holdings reported by Daniel Lang for Athenex, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
81,590 |
$110,962 |
$1.36 |
16 Sep 2022 |
Direct |
|
|
| Stock Option (Right to Buy) |
200,000 |
|
|
16 Sep 2022 |
Direct |
Common Stock |
200,000 |
| Restricted Stock Units |
37,500 |
|
|
16 Sep 2022 |
Direct |
Common Stock |
|
Transactions reported by Daniel Lang for Athenex, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.